The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.

The FDA approved a pain drug designed to eliminate the risks associated with opioids -- the first new pharmaceutical approach ...